These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 9192825

  • 1. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.
    Piazza GA, Rahm AK, Finn TS, Fryer BH, Li H, Stoumen AL, Pamukcu R, Ahnen DJ.
    Cancer Res; 1997 Jun 15; 57(12):2452-9. PubMed ID: 9192825
    [Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA.
    Cancer Res; 2002 Nov 01; 62(21):6323-8. PubMed ID: 12414664
    [Abstract] [Full Text] [Related]

  • 3. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K.
    Int J Oncol; 2003 Sep 01; 23(3):665-72. PubMed ID: 12888902
    [Abstract] [Full Text] [Related]

  • 4. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R, Kusunoki M, Yanagi H, Noda M, Furuyama JI, Yamamura T, Hashimoto-Tamaoki T.
    Cancer Res; 2001 Feb 01; 61(3):1029-37. PubMed ID: 11221829
    [Abstract] [Full Text] [Related]

  • 5. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S, Tegeder I, Niederberger E, Bräutigam L, Geisslinger G.
    FASEB J; 2001 Dec 01; 15(14):2742-4. PubMed ID: 11606477
    [Abstract] [Full Text] [Related]

  • 6. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.
    Piazza GA, Rahm AL, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burt RW, Alberts DS, Pamukcu R.
    Cancer Res; 1995 Jul 15; 55(14):3110-6. PubMed ID: 7606732
    [Abstract] [Full Text] [Related]

  • 7. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells.
    Moon EY, Lerner A.
    Cancer Res; 2002 Oct 15; 62(20):5711-9. PubMed ID: 12384529
    [Abstract] [Full Text] [Related]

  • 8. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM.
    Cancer Res; 2000 Dec 15; 60(24):6846-50. PubMed ID: 11156377
    [Abstract] [Full Text] [Related]

  • 9. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.
    Molina MA, Sitja-Arnau M, Lemoine MG, Frazier ML, Sinicrope FA.
    Cancer Res; 1999 Sep 01; 59(17):4356-62. PubMed ID: 10485483
    [Abstract] [Full Text] [Related]

  • 10. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ.
    Cancer Res; 2000 Oct 15; 60(20):5767-72. PubMed ID: 11059772
    [Abstract] [Full Text] [Related]

  • 11. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
    Maier TJ, Schilling K, Schmidt R, Geisslinger G, Grösch S.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1469-78. PubMed ID: 15041464
    [Abstract] [Full Text] [Related]

  • 12. Antiproliferative effects of nitrosulindac on human colon adenocarcinoma cell lines.
    Lavagna C, Burgaud JL, Del Soldato P, Rampal P.
    Biochem Biophys Res Commun; 2001 Jun 15; 284(3):808-16. PubMed ID: 11396974
    [Abstract] [Full Text] [Related]

  • 13. Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S- or R-ibuprofen treatment.
    Janssen A, Maier TJ, Schiffmann S, Coste O, Seegel M, Geisslinger G, Grösch S.
    Eur J Pharmacol; 2006 Jul 01; 540(1-3):24-33. PubMed ID: 16730702
    [Abstract] [Full Text] [Related]

  • 14. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
    Elder DJ, Halton DE, Hague A, Paraskeva C.
    Clin Cancer Res; 1997 Oct 01; 3(10):1679-83. PubMed ID: 9815550
    [Abstract] [Full Text] [Related]

  • 15. Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine.
    Lawson KR, Ignatenko NA, Piazza GA, Cui H, Gerner EW.
    Cancer Epidemiol Biomarkers Prev; 2000 Nov 01; 9(11):1155-62. PubMed ID: 11097222
    [Abstract] [Full Text] [Related]

  • 16. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.
    Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455
    [Abstract] [Full Text] [Related]

  • 17. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
    Erickson BA, Longo WE, Panesar N, Mazuski JE, Kaminski DL.
    J Surg Res; 1999 Jan 15; 81(1):101-7. PubMed ID: 9889067
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.
    Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, Abreu-Goris M, Newmark HL, Lipkin ML, DeCosse JJ, Bertagnolli MM.
    Cancer Res; 1996 Jun 01; 56(11):2556-60. PubMed ID: 8653697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.